[Malignant melanoma: hepatic intra-arterial chemotherapy].
Khayat
D
D
Hôpital Pitié-Salpêtrière, Paris, France.
Cour
V
V
Aigner
C
C
Audhuy
B
B
Borel
C
C
Cohen-Aloro
G
G
Banzet
P
P
Weil
M
M
Buthiau
D
D
Bizzari
J P
JP
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008545:Melanoma / Q000473:pathology*; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced; D012878:Skin Neoplasms / Q000473:pathology*; D013921:Thrombocytopenia / Q000139:chemically induced
D000970:Antineoplastic Agents
Mélanomes malins: chimiothérapie intra-artérielle hépatique (ciah).